Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank

[1]  C. Haiman,et al.  Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer , 2021, Journal of the National Cancer Institute.

[2]  Lara E Sucheston-Campbell,et al.  Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry. , 2021, Journal of the National Cancer Institute.

[3]  James M. Hodge,et al.  A Population-Based Study of Genes Previously Implicated in Breast Cancer. , 2021, The New England journal of medicine.

[4]  K. D. Sørensen,et al.  Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction , 2021, Nature genetics.

[5]  D. Easton,et al.  CanRisk Tool—A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[6]  Jaana M. Hartikainen,et al.  Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. , 2021, The New England journal of medicine.

[7]  S. Cross,et al.  Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. , 2020, American journal of human genetics.

[8]  C. Kooperberg,et al.  Improving reporting standards for polygenic scores in risk prediction studies , 2020, Nature.

[9]  M. Abdolell,et al.  Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening , 2020, European Radiology.

[10]  J. Denny,et al.  Evaluating the Utility of Polygenic Risk Scores in Identifying High-Risk Individuals for Eight Common Cancers , 2020, JNCI cancer spectrum.

[11]  B. Meiser,et al.  Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field , 2020, Breast Cancer Research.

[12]  Aung Ko Win,et al.  A New Comprehensive Colorectal Cancer Risk Prediction Model Incorporating Family History, Personal Characteristics, and Environmental Factors , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[13]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[14]  K. D. Sørensen,et al.  Polygenic hazard score is associated with prostate cancer in multi-ethnic populations , 2019, Nature Communications.

[15]  Dustin N. Hartzel,et al.  A genome-first approach to aggregating rare genetic variants in LMNA for association with electronic health record phenotypes , 2019, Genetics in Medicine.

[16]  M. Feldman,et al.  Analysis of polygenic risk score usage and performance in diverse human populations , 2019, Nature Communications.

[17]  Alicia R. Martin,et al.  Clinical use of current polygenic risk scores may exacerbate health disparities , 2019, Nature Genetics.

[18]  M. García-Closas,et al.  BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors , 2019, Genetics in Medicine.

[19]  Kristen S Purrington,et al.  Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes , 2018, American Journal of Human Genetics.

[20]  V. Viallon,et al.  Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts , 2018, Breast Cancer Research.

[21]  Helen E. Parkinson,et al.  The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 , 2018, Nucleic Acids Res..

[22]  O. Andreassen,et al.  Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts , 2018, British Medical Journal.

[23]  P. Visscher,et al.  Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores , 2015, bioRxiv.

[24]  Carson C Chow,et al.  Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.

[25]  Stephen W Duffy,et al.  Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I , 2014, Breast Cancer Research.

[26]  K. Czene,et al.  Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement , 2012, Breast Cancer Research.

[27]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[28]  Susanne B Haga,et al.  Impact of limited population diversity of genome-wide association studies , 2010, Genetics in Medicine.

[29]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[30]  Genome-wide association studies of cancer: current insights and future perspectives , 2022 .